Open AccessCase report: treatment of metastatic renal cell carcinoma with nivolumab plus cabozantinib in routine clinical practice
Author(s) -
К. V. Menshikov,
А. В. Султанбаев,
A. A. Izmailov,
Ш. И. Мусин,
I. A. Menshikovа,
V. S. Chalov,
Н. И. Султанбаева,
Д. О. Липатов
Publication year - 2022
Publication title -
zlokačestvennye opuholi
Language(s) - English
Resource type - Journals
eISSN - 2587-6813
pISSN - 2224-5057
DOI - 10.18027/2224-5057-2022-12-2-45-51
Subject(s) - cabozantinib , sunitinib , nivolumab , renal cell carcinoma , medicine , oncology , kidney cancer , cancer , adverse effect , carcinoma , immunotherapy